Navigation Links
Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting
Date:2/29/2008

Data presented at national conference provides important insight into how

underutilization of treatments is jeopardizing quit attempts

PORTLAND, Ore., Feb. 29 /PRNewswire-FirstCall/ -- Leading researchers in the field of smoking cessation are gathering at the annual meeting of the Society for Research on Nicotine and Tobacco (SRNT) to present the latest research on smoking cessation, including a new study revealing smokers' misperceptions about cessation treatments.

The study's findings indicate smokers dramatically underestimate the safety and efficacy of nicotine replacement therapy (NRT) products for quitting smoking, which may lead to less use of proven smoking cessation therapy that has been proven to double a smoker's chances of quitting.(1,2) Presentation findings were based on a study of 900 men and women adult smokers in the U.S.(1)

Seventy-six percent of smokers wrongly believe or do not know whether NRT is more addictive than cigarettes.(1) Additionally, 68 percent of smokers wrongly answered or do not know that NRT products are as dangerous as cigarettes.(1) Less than three percent of respondents answered all questions about treatment correctly, demonstrating the enormous need for further education.(1,3)

The good news is that even if smokers held these misperceptions, about half of them stated they would be more likely to consider NRT if they were shown scientific evidence that proves its safety.(1)

"Cessation treatments like nicotine replacement therapy have been proven to greatly increase the chances of successfully quitting," said Dr. Donna Vallone, Senior Vice President, Research and Evaluation American Legacy Foundation. "The research findings only reinforce the point that treatments for cessation are underutilized thereby jeopardizing successful attempts at quitting. More needs to be done to educate smokers."

The majority of smokers try to quit "cold turkey," yet only 3-5 percent of smokers wh
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
2. Montana State University lab gives early warnings about biological invaders
3. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
4. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
5. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
6. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
7. Stevens researchers provide new information about mass spectrometry
8. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating
9. Evotec Starts Phase II in Smoking Cessation with EVT 302
10. Laser Therapy Gives Smokers Hope for Successful New Years Resolution
11. Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment ...ins the only one to show consistent growth during ... hospitals remain in trouble, and health systems a... personnel, instead of just administrators. , ...Health care employment continued growing in Octobe...
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... The FBI recently approved...oratories participating in or generating DNA recor... Madison, WI USA (PRWEB) -- The FBI ...S System for use by laboratories participating in...Index System (NDIS). NDIS currently contains more ...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
... more than 100 people have been infected with the ...act with infected poultry, the fact that the virus...hosts to other humans has been a biomedical puzzle...y tract reveals a simple anatomical difference in ...r the virus to jump from human to human. , ,The fi...
...the good fortune to be in Zurich, Switzerland less...s biotech companies and the Swiss Biotech Associat...panies organized by the Swiss Business Hub here in...1 years (although I had been to Basel, Lausanne, a...ich in 1985 was part of a roadshow to raise $15 mi...
...s of the new Taxpayer Bill of Rights proposal are ...tion: that revenue limits on state, county, and mu...nsin,s business climate. , ,TABOR, they say, place...y investment, in jeopardy. , ,Based in part on Col...omic development would be handcuffed should the me...
Other Biology Technology:UW shows why avian flu hasn't spread among humans yet 2UW shows why avian flu hasn't spread among humans yet 3Swiss biotech has quality of its big pharma, watch and chocolate industries 2Swiss biotech has quality of its big pharma, watch and chocolate industries 3Swiss biotech has quality of its big pharma, watch and chocolate industries 4Swiss biotech has quality of its big pharma, watch and chocolate industries 5Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5
(Date:11/24/2009)...RK (November 24, 2009) -- The Wildlife Conservatio... that the last remaining population of Siberian ti...rising tide of poaching and habitat loss. , ...an officials of what needs to be done to protect r..., The report was released by the Sib...
(Date:11/24/2009)...able in Spanish . , The presence of increas...matory substances in the blood, hinders the loss a...rch project of the University of Navarra conducted...chool of Pharmacy. , The project, entitled "A nu...he control of body weight and inflammation," exami...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2The MedZilla Report for September 2009 Care Grows Again in September and Surprisingly Pharma Sales Jobs Up Too 14624 1The MedZilla Report for September 2009 Care Grows Again in September and Surprisingly Pharma Sales Jobs Up Too 14624 2The MedZilla Report for September 2009 Care Grows Again in September and Surprisingly Pharma Sales Jobs Up Too 14624 3The MedZilla Report for September 2009 Care Grows Again in September and Surprisingly Pharma Sales Jobs Up Too 14624 4PHSI INC Develops Revolutionary Vision Hearing Program 60210 1PHSI INC Develops Revolutionary Vision Hearing Program 60210 2Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 1Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 2Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 3
...uthern pine beetle moves through the forest boring...it both a helper and a competitor. The helper is a...as food for its young. But also riding along is a ...ungus for feeding its own larvae. , Now the pictu... grown even more curious. Writing in the Oct. 3 is...
...s and live cell experiments, biomedical engineers ... have discovered more than 100 human protein fragm...t make up new blood vessels. , Reporting online ...emy of Sciences, the researchers say the findings...ases that depend on the growth of new blood vessel...
...tober 3, 2008Novel platform technologies and key a...pment of molecular diagnostics, reports Genetic E...ff for successful molecular diagnostic products ca...that this market currently exceeds $3.2 billion wo... according to an article in the October 1 issue of...
Other Biology News:Wielding microbe against microbe, beetle defends its food source 2Wielding microbe against microbe, beetle defends its food source 3Discovery of natural compounds that could slow blood vessel growth 2Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2
Rabbit Anti-5-HYDROXYTRYPTOPHAN CONJUGATE Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
IMAGEQUANT 100 IQTL from GE Healthcare, formerly Amersham Biosciences
Cathepsin L Fluorometric (cresyl violet) Assay Kit, Magic Red from AbD Serotec
Biology Products: